Christopher Cox

Mr Cox has been a partner at Cadwalader, Wickersham & Taft LLP in New York since January 2012. Previously the Chairman of Cadwalader's Department and a Member of its Management Committee, he advises clients on a of corporate and financial matters, including mergers and acquisitions and restructurings, spin-offs, joint ventures, IP monetizations and other financing transactions. From February 2016 to March 2019, he was seconded to The Medicines Company, a biopharmaceutical company, where he served as Executive Vice President and Chief Corporate Development Officer and was in charge for business development and strategy. Prior to January 2012, he was a partner at Cahill Gordon & Reindel LLP in New York. He also serves as the Chief Executive Officer of Symphony Capital Holdings, LLC, a investment holding company with interests in biotechnology, network security and entertainment. He was also a Member of the Missouri Law Review.